{"id_": "1239238122384363520", "raw_data": {"created_at": "Sun Mar 15 17:12:46 +0000 2020", "id": 1239238122384363520, "id_str": "1239238122384363520", "full_text": "CureVac focuses on the development of a mRNA-based coronavirus vaccine to protect people worldwide. We abstain from commenting on speculations and rejects allegations about offers for acquisition of our company or our technology. \nTo our press release: https://t.co/DQGWgdcUJc", "truncated": false, "display_text_range": [0, 276], "entities": {"hashtags": [], "symbols": [], "user_mentions": [], "urls": [{"url": "https://t.co/DQGWgdcUJc", "expanded_url": "https://www.curevac.com/news/curevac-focuses-on-the-development-of-mrna-based-coronavirus-vaccine-to-protect-people-worldwide", "display_url": "curevac.com/news/curevac-fâ€¦", "indices": [253, 276]}]}, "source": "<a href=\"https://mobile.twitter.com\" rel=\"nofollow\">Twitter Web App</a>", "in_reply_to_status_id": null, "in_reply_to_status_id_str": null, "in_reply_to_user_id": null, "in_reply_to_user_id_str": null, "in_reply_to_screen_name": null, "user_id": 989045379445510145, "user_id_str": "989045379445510145", "geo": null, "coordinates": null, "place": null, "contributors": null, "is_quote_status": false, "retweet_count": 1232, "favorite_count": 3893, "reply_count": 283, "quote_count": 301, "conversation_id": 1239238122384363520, "conversation_id_str": "1239238122384363520", "favorited": false, "retweeted": false, "possibly_sensitive": false, "possibly_sensitive_editable": true, "lang": "en", "supplemental_language": null}}